On Thursday, Shares of Yahoo! Inc. (NASDAQ:YHOO), subtract -1.75% and closed at $41.62 in the last trading session. The last trading range of the stock ranges between $41.17 and $42.08. Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC declares that a class action lawsuit has been filed against Yahoo! Inc. (“Yahoo” or the “Company”) (YHOO) regarding an unprecedented security breach affecting nearly 500 million users.
On September 22, 2016, Yahoo revealed that a “recent investigation” confirmed that sensitive personal account information of at least 500 million account users “was stolen from the company’s network in late 2014 by what it believes is a state-sponsored attack.” Users’ names, email addresses, phone numbers, dates of birth, hashed passwords, and in some cases encrypted or unencrypted security questions and answers were included in the data breach.
The Complaint alleges that Yahoo’s actions were reckless as they disregarded the safety and security of Yahoo users’ personal information. The Complaint claims that Yahoo should be held responsible for their insufficiencies and the damages caused to its users. Unlike several other recent data breaches, Yahoo has not offered users any assistance with identity theft protection, while Yahoo users are now at a greater risk of having their identities stolen and must find their own way and pay to protect themselves.
Exelixis, Inc.(NASDAQ:EXEL), dropped -0.17% and closed at $11.91 in the last trading session. The last trading range of the stock ranges between $11.39 and $12.09. The company’s Market capitalization is $2.58 Billion with the total outstanding Shares of 230.33 million. Exelixis, Inc. (EXEL) recently declared detailed results from the CABOSUN randomized phase 2 trial of cabozantinib in patients with formerly untreated advanced renal cell carcinoma (RCC) with intermediate- or poor-risk disease per the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). Principal investigator Toni K. Choueiri, M.D. will present detailed data from late-breaking CABOSUN abstract [#LBA30_PR] recently in the Presidential Symposium 3 session, starting at 16:30 CEST (local Copenhagen time) / 10:30 a.m. EDT / 7:30 a.m. PDT at the European Society for Medical Oncology (ESMO) 2016, which is being held October 7 – 11, 2016 in Copenhagen.
In CABOSUN, with a median follow-up of 20.8 months, cabozantinib demonstrated a clinically meaningful and statistically noteworthy31 percent reduction in the rate of disease progression or death [HR 0.69, 95% CI (0.48-0.99), one-sided P=0.012]. The median progression-free survival (PFS) for cabozantinib was 8.2 months as compared to 5.6 months for sunitinib, corresponding to a 2.6 months (46 percent) improvement favoring cabozantinib over sunitinib. PFS benefits were independent of IMDC risk group (intermediate or poor risk) and presence or absence of bone metastases at baseline. The results for sunitinib were in line with a formerly published retrospective analysis of 1,174 intermediate- and poor-risk RCC patients from the IMDC database, which documented a median PFS of 5.6 months with a first-line targeted therapy, mainly sunitinib, in this patient population.1
Boeing Co (NYSE:BA), jumped 0.19% and closed at $133.38 in the last trading session. The last trading range of the stock ranges between $131.39 and $133.93. During the 52-week trading session the minimum price at which share price traded, registered at $102.10 and reached to max level of $150.59. Boeing [NYSE: BA] has been recognized by The National Business Group on Health for having one of the best workforce well-being programs in the nation.
The National Business Group on Health, a non-profit association of 425 large U.S. employers, recognized the company with a Platinum Award for Boeing’s Well Being program, which provides a suite of tools, activities and resources to holistically support physical, financial and emotional well-being. In addition to the Platinum award, Boeing was one of just five companies receiving the Top Honors designation from the panel of judges.
“We are honored to receive this important recognition of our efforts to provide holistic mind and body well-being programs and benefits,” said Heidi Capozzi, senior vice president of Human Resources. “Boeing is committed to supporting our employees as they tirelessly innovate to connect, protect, explore and inspire the world.”
Boeing’s Well Being Program includes: an annual company-wide physical activity challenge that this year enrolled more than 100,000 employees; confidential health screenings and an online health assessment; health coaching, free flu vaccines, smoking cessation, fitness and weight administration programs; job conditioning and on-site rehabilitation programs to reduce risk of injury and improve physical function, in addition to healthy eating options at company facilities.